Abbott completes enrollment in cardiac study

The study will focus on “vulnerable” plaque, a lipid-rich coronary plaque that suddenly ruptures, believed to be the cause of most heart attacks. The study enrolled 700 acute coronary syndrome patients in the US and Europe. Patients will be followed up for at least two, and up to five, years.

The study utilizes novel intravascular imaging technology to correlate plaque characteristics, patient risk factors and biomarker measurements with subsequent heart attacks and other cardiac events, potentially paving the way for physicians to identify and treat at-risk patients before a heart attack occurs.

Dr Gregg Stone, principal investigator of the study will present data from the first group of patients enrolled in October at the Eighteenth Annual Scientific Symposium in Washington, D.C.